The association between age and adverse events due to biologic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis: A retrospective cohort study

We examined whether the age of patients with rheumatoid arthritis was associated with adverse events (AEs) caused by biologic disease-modifying antirheumatic drugs (bDMARDs). Patients with rheumatoid arthritis using bDMARDs from Showa University Hospital, Showa University Northern Yokohama Hospital,...

Descripción completa

Detalles Bibliográficos
Autores principales: Ikari, Yuzo, Yajima, Nobuyuki, Miwa, Yusuke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
6900
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7769304/
https://www.ncbi.nlm.nih.gov/pubmed/33350780
http://dx.doi.org/10.1097/MD.0000000000023861

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7769304/
https://www.ncbi.nlm.nih.gov/pubmed/33350780
http://dx.doi.org/10.1097/MD.0000000000023861

Ejemplares similares